We are here to meet new challenges to provide you the best, in accordance with current Good Manufacturing Practices (cGMP) Lisko’s manufacturing facility is the manifestation of over a decade of planning and hard work. Today’s pharmaceutical manufacturing facilities bear little resemblance to those of even a decade ago.
More modular construction platforms will be available, each with its own distinct identity and strengths. In addition, new single-use process equipment and contained process equipment and cleanrooms enable dramatic increases in flexibility and reductions in capital costs. Ampoule manufacturing facilities also will be transform by new production platforms and better plant design.
As far Lisko has a strong portfolio of Oral Solid and Liquid dosage forms and is confident to maintain its standard in the upcoming semisolid (including creams, general ointments and steroidal ointment) and unit dose delivery system (sachet). Dedicated ware-housing activities along with CGMP compliant Dispensing and Sampling Booths will be provided. The automatic manufacturing technology of external liquids will be provided to meet customer requirements.
A seperate and completely dedicated Psychotropic plant will be completed, which when come into operation will provide tablets, capsules and injectables. , The cephalosporins injectables section will also be finalized soon to provide quality medicines.